Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 272 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/03/22
End: 04/22/24
Due: 04/22/25
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 02/02/27
Due: 02/02/28
Phase: N/A
Priority: Normal
Start: 12/19/19
End: 12/20/25
Due: 12/20/26
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 12/21/20
End: 04/16/21
Due: 04/16/22
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 06/05/19
End: 03/08/22
Due: 03/08/23
Phase: N/A
Priority: Normal
Start: 09/01/16
End: 09/09/18
Due: 09/09/19
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 01/10/22
End: 07/15/22
Due: 07/15/23
Phase: N/A
Priority: Normal
Start: 08/08/22
End: 12/15/22
Due: 12/15/23
A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 05/28/25
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 06/15/25
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 12/13/18
End: 11/12/20
Due: 11/12/21
Phase: N/A
Priority: Normal
Start: 05/01/18
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 09/01/18
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 02/01/14
End: 03/17/22
Due: 03/17/23
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 06/01/27
Due: 06/01/28
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 06/18/21
Due: 06/18/22
Phase: N/A
Priority: Normal
Start: 04/25/25
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 04/30/10
Due: 04/30/11